Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (481-490 of 606) with videos related to

Pageof 61
Sort By:
Journal of Medicinal Chemistry|January 9, 2004
Discovery of the first N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphan to possess highly potent and selective opioid delta receptor antagonist activityF Ivy Carroll, Li Zhang, S Wayne Mascarella, et al.
Journal of Medicinal Chemistry|April 20, 2001
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacyS McLamore, T Ullrich, R B Rothman, et al.
Journal of Medicinal Chemistry|May 10, 1996
Probes for narcotic receptor-mediated phenomena. 21. Novel derivatives of 3-(1,2,3,4,5,11-hexahydro-3-methyl-2,6-methano-6H-azocino[4,5-b]indol- 6-yl)-phenols with improved delta opioid receptor selectivityC M Bertha, M Ellis, J L Flippen-Anderson, et al.
Neuropeptides|May 1, 1984
Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric modelR B Rothman, W D Bowen, V Bykov, et al.
Molecular and Cellular Biology|October 17, 1998
Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferationN N Danial, J A Losman, T Lu, et al.
Journal of Medicinal Chemistry|March 8, 2002
Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazineLing-Wei Hsin, Christina M Dersch, Michael H Baumann, et al.
Neuropharmacology|September 1, 1988
Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanismsJ A Danks, F C Tortella, J B Long, et al.
The Journal of Biological Chemistry|April 2, 2011
The developmental regulator protein Gon4l associates with protein YY1, co-repressor Sin3a, and histone deacetylase 1 and mediates transcriptional repressionPing Lu, Isaiah L Hankel, Bruce S Hostager, et al.
European Journal of Pharmacology|November 27, 2012
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogsNicholas V Cozzi, Simon D Brandt, Paul F Daley, et al.
Journal of Medicinal Chemistry|August 24, 2000
Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomersM S Furness, X Zhang, A Coop, et al.
Pageof 61

Showing results (481-490 of 606) with videos related to

Sort By:
Pageof 61
Journal of Medicinal Chemistry|January 9, 2004
Discovery of the first N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphan to possess highly potent and selective opioid delta receptor antagonist activityF Ivy Carroll, Li Zhang, S Wayne Mascarella, et al.
Journal of Medicinal Chemistry|April 20, 2001
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacyS McLamore, T Ullrich, R B Rothman, et al.
Journal of Medicinal Chemistry|May 10, 1996
Probes for narcotic receptor-mediated phenomena. 21. Novel derivatives of 3-(1,2,3,4,5,11-hexahydro-3-methyl-2,6-methano-6H-azocino[4,5-b]indol- 6-yl)-phenols with improved delta opioid receptor selectivityC M Bertha, M Ellis, J L Flippen-Anderson, et al.
Neuropeptides|May 1, 1984
Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric modelR B Rothman, W D Bowen, V Bykov, et al.
Molecular and Cellular Biology|October 17, 1998
Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferationN N Danial, J A Losman, T Lu, et al.
Journal of Medicinal Chemistry|March 8, 2002
Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazineLing-Wei Hsin, Christina M Dersch, Michael H Baumann, et al.
Neuropharmacology|September 1, 1988
Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanismsJ A Danks, F C Tortella, J B Long, et al.
The Journal of Biological Chemistry|April 2, 2011
The developmental regulator protein Gon4l associates with protein YY1, co-repressor Sin3a, and histone deacetylase 1 and mediates transcriptional repressionPing Lu, Isaiah L Hankel, Bruce S Hostager, et al.
European Journal of Pharmacology|November 27, 2012
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogsNicholas V Cozzi, Simon D Brandt, Paul F Daley, et al.
Journal of Medicinal Chemistry|August 24, 2000
Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomersM S Furness, X Zhang, A Coop, et al.
Pageof 61